Questions: Nutrient Bioconversion and Metabolic Activation

Question 1

A person following a strict plant-based diet consumes 12 mcg of dietary beta-carotene from carrots each day and no preformed retinol. Approximately how much retinol activity does this provide?

• A. 12 mcg retinol activity equivalents — beta-carotene is a direct form of vitamin A
• B. 1 mcg retinol activity equivalent — due to the approximately 12:1 conversion ratio
• C. 144 mcg retinol activity equivalents — beta-carotene is more potent than preformed retinol
• D. 6 mcg retinol activity equivalents — conversion efficiency is approximately 50%

Answer: (B)

The conversion of dietary beta-carotene to retinol is approximately 12:1 — it takes 12 mcg of dietary beta-carotene to yield 1 mcg of retinol activity. This ratio worsens further when dietary fat is low (beta-carotene requires fat for micellar absorption). This is why plant-based diets heavy in carrots and sweet potatoes can leave people deficient in vitamin A despite high beta-carotene intake.

Question 2

Two people consume identical amounts of ALA (alpha-linolenic acid from flaxseed oil). Person A eats a diet high in vegetable oils (rich in omega-6 linoleic acid); Person B eats a diet low in omega-6. After several weeks, whose blood EPA and DHA levels would you expect to be higher, and why?

• A. Person A — more total fat intake supports more efficient fatty acid metabolism
• B. Both would be similar — ALA conversion efficiency does not depend on other dietary fats
• C. Person B — the desaturase and elongase enzymes are less occupied by omega-6 substrates, leaving more capacity to convert ALA to EPA and DHA
• D. Person A — higher omega-6 upregulates the FADS enzymes, increasing ALA conversion

Answer: (C)

The conversion of ALA to EPA and DHA depends on desaturase (FADS1/FADS2) and elongase enzymes that also process omega-6 fatty acids. When omega-6 intake is high, these enzymes are largely occupied, leaving little capacity for ALA conversion. Person B, with lower omega-6 competition, would likely achieve higher EPA/DHA from the same ALA intake. This is one reason preformed EPA/DHA from fatty fish or algae produce very different blood lipid outcomes than equivalent ALA.

Question 3

Two individuals with different single nucleotide polymorphisms in the BCMO1 gene may achieve very different vitamin A status despite consuming identical diets rich in beta-carotene.

• T. True
• F. False

Answer: True

BCMO1 encodes the carotenoid oxygenase enzyme that cleaves beta-carotene into retinol. SNPs in this gene create meaningful variation in conversion efficiency across individuals — some people are efficient converters, others are 'poor converters' who respond weakly to provitamin A forms regardless of intake. This is why nutritional recommendations increasingly distinguish between preformed retinol and beta-carotene forms, and why supplementation studies must account for participants' genetic backgrounds.

Question 4

Plant-based omega-3 (ALA from flaxseed and walnuts) is nutritionally equivalent to preformed EPA and DHA from fatty fish, because the body reliably converts ALA into the longer-chain forms needed for biological function.

• T. True
• F. False

Answer: False

ALA conversion to EPA is only about 5–10%, and conversion to DHA is far lower still. This is one of the most clinically important examples of the bioconversion problem — the precursor is present in food, but conversion to the active forms is inefficient and competed for by omega-6 fatty acids. Blood lipid and inflammatory responses to ALA supplementation differ substantially from responses to preformed EPA/DHA supplementation.

Question 5

Why can't you assume that consuming a provitamin in a given amount meets the same nutritional need as consuming the active vitamin in an equal amount? What factors determine whether provitamin intake is adequate?

Model answer: A provitamin must be enzymatically converted to its active form, and this conversion is lossy and variable. Conversion efficiency depends on: (1) the intrinsic efficiency ratio (e.g., 12:1 for beta-carotene, 60:1 for tryptophan-to-niacin); (2) dietary factors like fat intake affecting absorption; (3) competition from other substrates for shared enzymes; and (4) individual genetic variation in biosynthetic enzymes. Adequate provitamin intake requires consuming enough to produce sufficient active metabolite after all these losses.

The practical implication is that dietary recommendations distinguish between provitamin and active vitamin forms — for vitamin A, between retinol activity equivalents (RAE) and dietary beta-carotene; for omega-3, between EPA/DHA and ALA. A person relying on provitamin sources may need substantially more food-derived precursor than a person consuming the active form directly.